Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 5,838 | 4,528 | 5,501 | 5,686 | 4,524 |
| Cost of Goods | 3,481 | 2,027 | 1,702 | 3,297 | 2,531 |
| Gross Profit | 2,357 | 2,501 | 3,799 | 2,389 | 1,993 |
| Operating Expenses | 7,968 | 5,932 | 9,546 | 6,205 | 5,315 |
| Operating Income | -5,131 | -3,403 | -5,045 | -3,519 | -2,791 |
| Other Income | 27 | -5 | 33 | -15 | -17 |
| Pre-tax Income | -5,103 | -3,408 | -5,012 | -3,534 | -2,807 |
| Net Income Continuous | -5,103 | -3,408 | -5,012 | -3,534 | -2,807 |
| Net Income | $-5,103 | $-3,408 | $-5,012 | $-3,534 | $-2,807 |
| EPS Basic Total Ops | -0.04 | -0.03 | -0.04 | -0.03 | -0.03 |
| EPS Basic Continuous Ops | -0.04 | -0.03 | -0.04 | -0.03 | -0.03 |
| EPS Diluted Total Ops | -0.04 | -0.03 | -0.04 | -0.03 | -0.03 |
| EPS Diluted Continuous Ops | -0.04 | -0.03 | -0.04 | -0.03 | -0.03 |
| EBITDA(a) | $-4,987 | $-3,269 | $-4,925 | $-3,416 | $-2,762 |